Endo Pays $10M To Exit Opioid MDL Bellwethers
Endo Pharmaceuticals Inc. on Tuesday announced it will pay $10 million and donate up to $1 million in prescription drugs to exit the lead bellwether cases in multidistrict opioid litigation....To view the full article, register now.
Already a subscriber? Click here to view full article